| Line 456: | Line 456: | ||
*Lower baseline cotinine predicted greater smoking reduction. | *Lower baseline cotinine predicted greater smoking reduction. | ||
*Citation: Dana Rubenstein, Alexander W. Sokolovsky, Elizabeth R. Aston, Nicole L. Nollen, Christopher H. Schmid, Myra Rice, Kim Pulvers, Jasjit S. Ahluwalia, Predictors of smoking reduction among african american and latinx smokers in a randomized controlled trial of JUUL e-cigarettes, Addictive Behaviors, 2021, 107037, ISSN 0306-4603, doi: 10.1016/j.addbeh.2021.107037 | *Citation: Dana Rubenstein, Alexander W. Sokolovsky, Elizabeth R. Aston, Nicole L. Nollen, Christopher H. Schmid, Myra Rice, Kim Pulvers, Jasjit S. Ahluwalia, Predictors of smoking reduction among african american and latinx smokers in a randomized controlled trial of JUUL e-cigarettes, Addictive Behaviors, 2021, 107037, ISSN 0306-4603, doi: 10.1016/j.addbeh.2021.107037 | ||
===2021: [https://pubmed.ncbi.nlm.nih.gov/34215994/ Patterns of E-Cigarette Use Among Primary Care Patients at an Urban Community Center]=== | |||
*Among primary care patients at a community health center, e-cigarette use was reported by a sizeable portion of the sample. Overall, odds of use were higher in certain patient populations, and individuals who formally used cigarettes were more likely to report e-cigarette use than individuals who currently smoke, suggesting that e-cigarettes may be functioning as a cessation aid or a strategy to reduce conventional cigarette use. | |||
*Citation: O'Cleirigh C, King D, Stanton AM, Goldin A, Kirakosian N, Crane HM, Grasso C. Patterns of E-Cigarette Use Among Primary Care Patients at an Urban Community Center. J Community Health. 2021 Jul 2. doi: 10.1007/s10900-021-01015-x. Epub ahead of print. PMID: 34215994. | |||
*Acknowledgement: The data is owned by a third-party organization (Fenway Health), and the organization’s IRB restricts access to patient data, due to concerns over a risk of inadvertent disclosure of personal health information. Given that the data are abstracted from patients’ primary care medical visits, the preparation of deidentified data is not permitted. Researchers with a reasonable request for a deidentified data set can contact the Fenway Health IRB | |||
| Line 496: | Line 502: | ||
*In conclusion, to reduce smoking and to save millions of lives, tobacco harm reduction in the form of cigarette substitution with low-risk products appears to be a promising path. These products, although not completely risk-free, offer an alternative to quit or die. In consideration of the available evidence, advice to tobacco smokers should include trying substitute products. The obvious fact so often overlooked is that smoking is rewarding and people like to do it. Giving smokers an alternative with efficient nicotine delivery means that they might prefer one of these products over cigarettes. | *In conclusion, to reduce smoking and to save millions of lives, tobacco harm reduction in the form of cigarette substitution with low-risk products appears to be a promising path. These products, although not completely risk-free, offer an alternative to quit or die. In consideration of the available evidence, advice to tobacco smokers should include trying substitute products. The obvious fact so often overlooked is that smoking is rewarding and people like to do it. Giving smokers an alternative with efficient nicotine delivery means that they might prefer one of these products over cigarettes. | ||
*[https://www.emerald.com/insight/content/doi/10.1108/DAT-02-2020-0007/full/pdf?title=tobacco-harm-reduction-in-the-21st-century PDF Version] and [https://safernicotine.wiki/mediawiki/index.php/File:Ren%C3%A9e_O%E2%80%99Leary_and_Riccardo_Polosa.pdf PDF2] | *[https://www.emerald.com/insight/content/doi/10.1108/DAT-02-2020-0007/full/pdf?title=tobacco-harm-reduction-in-the-21st-century PDF Version] and [https://safernicotine.wiki/mediawiki/index.php/File:Ren%C3%A9e_O%E2%80%99Leary_and_Riccardo_Polosa.pdf PDF2] | ||
*Citation: O'Leary, R. and Polosa, R. (2020), "Tobacco harm reduction in the 21st century", Drugs and Alcohol Today, Vol. 20 No. 3, pp. 219-234. doi: 10.1108/DAT-02-2020-0007 | *Citation: O'Leary, R. and Polosa, R. (2020), "Tobacco harm reduction in the 21st century", Drugs and Alcohol Today, Vol. 20 No. 3, pp. 219-234. doi: 10.1108/DAT-02-2020-0007 | ||
| Line 552: | Line 558: | ||
*Citation: Manzoli L, Flacco ME, Ferrante M, et al. Cohort study of electronic cigarette use: effectiveness and safety at 24 months. Tob Control. 2017;26(3):284-292. doi:10.1136/tobaccocontrol-2015-052822 | *Citation: Manzoli L, Flacco ME, Ferrante M, et al. Cohort study of electronic cigarette use: effectiveness and safety at 24 months. Tob Control. 2017;26(3):284-292. doi:10.1136/tobaccocontrol-2015-052822 | ||
*Acknowledgement: The first 2 years of the study were unfunded. The next 3 years of follow-up are going to be funded through crowdfunding (Kickstarter project titled ‘E-cigarette long-term efficacy & safety: a study to complete’). | *Acknowledgement: The first 2 years of the study were unfunded. The next 3 years of follow-up are going to be funded through crowdfunding (Kickstarter project titled ‘E-cigarette long-term efficacy & safety: a study to complete’). | ||
===2017: [https://link.springer.com/article/10.1007%2Fs11606-017-4123-x Patterns of and reasons for electronic cigarette use in primary care patients]=== | |||
*In descriptive analyses, compared to never e-cigarette users, ever e-cigarette users were younger, non-Hispanic white, more educated, more likely to be daily smokers, smoked more cigarettes per day, and smoked their first cigarette within 30 min of waking. | |||
*Among current e-cigarette users, 84% reported using e-cigarettes to quit cigarettes, to cut down on cigarettes, or because they believe they are less harmful than cigarettes. The least common reason for use was cost (48%). Among former e-cigarette users, 78% reported using e-cigarettes to quit cigarettes, to cut down on cigarettes, or because they believe they are less harmful than cigarettes, and the least common reason was also cost (30%). | |||
*[https://link.springer.com/content/pdf/10.1007/s11606-017-4123-x.pdf PDF Version] | |||
*Citation: Kalkhoran, S., Alvarado, N., Vijayaraghavan, M. et al. Patterns of and reasons for electronic cigarette use in primary care patients. J GEN INTERN MED 32, 1122–1129 (2017). doi:10.1007/s11606-017-4123-x | |||
*Acknowledgement: This work was supported by NIH National Institute on Drug Abuse R01DA034253. | |||
edits